Eslicarbazepine Acetate
Therapeutic Category
- Anti-convulsant
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Eslicarbazepine, treats partial-onset seizures in patients aged 4 years and older. The EU and US Health Authorities have approved it for use as monotherapy or as additional therapy for partial-onset seizures in epilepsy. Similarly to oxcarbazepine, ESL behaves as a prodrug to (S)-(+)-licarbazepine.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Eslicarbazepine Acetate API with CAS Number: 236395-14-5. We are a leading exporter of Eslicarbazepine Acetate API with CAS Number: 236395-14-5. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Iran, Middle East and other emerging markets.
CTX Lifesciences is one of the leading API manufacturer & supplier of Eslicarbazepine Acetate API with CAS Number: 236395-14-5. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File(DMF). Our manufacturing plant at Surat has accreditation by US-FDA, EDQM , EMA , ANVISA, KFDA, MOH-IRAN, Health Canada & Russian Authorities.
Active Pharmaceutical Ingredient ( API ) products offered in the same Therapeutic Categories are as below.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.